Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Delivra Health Brands Inc V.DHB

Alternate Symbol(s):  DHBUF

Delivra Health Brands Inc. is a Canada-based company, which provides lifestyle, and health and wellness products to consumers and patients in regulated markets around the world. The Company's subsidiaries include Dream Water Global (Dream Water) and Delivra Corp. (Delivra). The Company’s portfolio features brands like Dream Water and LivRelief. Its Dream Water brand offers sleep aids in a range... see more

TSXV:DHB - Post Discussion

Delivra Health Brands Inc > Satipharm sale is good news - Products not selling
View:
Post by JDL on Feb 16, 2021 10:47am

Satipharm sale is good news - Products not selling

Selling Satipharm is an excellent strategic decision from my standpoint. The demand was very low and the investments required to distribute internationally would have been very high. They now have two excellent product line amongst best selling products in their respective category. Here is the abstract from a conversation with investors relation in 2020.
Satipharm Oil gone from Shoppers? Why?
United greeneries owns the sales license to Satipharm Oil on Shoppers, but Harvest One owns the IP and everything. Need to reapply or utilize the license loyalty if United Greeneries restocks.
Satipharm capsules in Canada, import or manufacture, where is it?
Import license only for R&D, still ongoing and is a priority for sales license. It needs a considerable amount of cash to get the project going so it is not a priority currently to manufacture in Canada.
So there we have it. Well priced CBD company with products flying from the shelves. End of March financials should give an indication of positive EBITDA in the very near future.
 
Comment by Claudetrader65 on Feb 16, 2021 10:57am
This post has been removed in accordance with Community Policy
Comment by BullRunner76 on Feb 16, 2021 11:01am
What's this guys problem? He sounds like Joemontreal for some reason! I guess he's trying to cover his shorts at $0.12. I came back to this board because I thought clowns like him stop posting BS. But I guess I was wrong.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities